Latest article: |
New Kits Provide Earlier Detection of Heart Damage
 13 Jul 2010: Alere International launches three improved tests for earlier detection of low levels of TnI which improves outcomes and benefits the patient. The kits are: Troponin I - a single-analyte, improved sensitivity Troponin I (TnI) test, Cardio2 - a two analyte panel consisting of the new Troponin I and BNP as well as Cardio3 - a three analyte panel consisting of the new Troponin I, BNP and CK-MB.
Alere International
|
|
|
Recent articles: |
|
New Early Rapid Test for Dengue Fever
 14 May 2010: Inverness Medical launches the new Panbio® Dengue Early Rapid immunochromatographic test for the early detection of dengue infection. Designed for use in conjunction with other dengue serology tests, the Dengue Early Rapid test can help to diagnose active dengue infection from the very first day fever appears.
Alere International
|
Second Study Supports that NGAL Test Identifies Acute Kidney Injury Early in Critically Ill Patients
03 Feb 2010: According to a recent study published in Intensive Care Medicine, a novel bedside blood test measured in critically ill patients being admitted to the intensive care unit can help to identify which patients are at risk for acute kidney injury (AKI). The study tested blood samples collected during admission to the ICU using the Triage® NGAL Test, a product currently sold by Inverness Medical Innovations, Inc. outside of the United States.*
Alere International
|
Clearview – Rapid Solutions for Detecting Malaria
07 Jul 2009: The Clearview® Malaria rapid test range from Inverness Medical provides a complete, rapid diagnostic solution for in vitro detection of malarial antigens in whole blood. This easy to use test is available in two different formats: Clearview® Malaria P.f. is a qualitative test for detecting the most common parasite, Plasmodium falciparum; Clearview® Malaria Combo detects and differentiates between the Plasmodium falciparum, P. vivax, P. malariae and P. ovale antigens.
Alere International
|
Rapid 4th generation POC HIV test identifies acute infection earlier than antibody only tests
 29 Jun 2009: Inverness Medical announce the new 4th generation rapid HIV diagnostic test – Determine® HIV 1/2 Ag/Ab Combo – capable of detecting HIV infection several days earlier than HIV antibody only tests and is ideal to help diagnose and screen for early HIV infection. The ability of this test to enhance the diagnosis of those with acute HIV infection will provide additional benefits in HIV prevention programs and ultimately contribute to a reduction in the spread of HIV.
Alere International
|
Accurate Answers for Osteoporosis Management Osteomark® NTx from Inverness Medical
27 Jan 2009: Osteoporosis affects 1 in 3 women and 1 in 5 men over 50, approximately 75 million people worldwide. Treatment of osteoporosis often involves the use of drugs to inhibit bone resorption, the primary cause of age-related bone loss. Inverness Medical offers the Osteomark® NTx range of ELISA products for monitoring patient response to anti-resorptive therapies.
Alere International
|
Rapid test, BinaxNOW®, detects Legionnaire’s Disease in 15 minutes
28 Oct 2008: The BinaxNOW® Legionella test, available from Inverness Medical provides significant time saving advantages over traditional sputum culture. Providing results in fifteen minutes from urine samples, BinaxNOW Legionella enables initiation of effective treatment at the first sign of infection.
Alere International
|
NEW rapid HIV test detects acute HIV infection
 04 Aug 2008: Inverness Medical has today announced the launch of its new 4th generation rapid HIV diagnostic test – Determine HIV-1/2 Ag/Ab Combo – at the International AIDS Conference (AIDS 2008) in Mexico City. Capable of detecting HIV infection several days earlier than HIV antibody only tests, Determine HIV-1/2 Ag/Ab Combo enables simultaneous separate detection of HIV p24 antigen (Ag) and antibodies (Ab) for HIV-1 and HIV-2 in human serum, plasma, or whole blood.
Alere International
|
The fightback against TB and HIV starts right here
 04 Aug 2008: Today, Inverness Medical is pleased to announce the launch of its new Clearview TB ELISA at the International AIDS Conference (AIDS 2008) in Mexico City. Tuberculosis (TB) is a leading cause of death in HIV infected patients, and the unique urine based Clearview TB ELISA LAM antigen test can provide a much needed aid in the diagnosis of TB in TB/HIV co-infected patients.
Alere International
|
Inverness Medical provides rapid detection of C. difficile infection in under 30 minutes
07 Jul 2008: Clostridium difficile disease is responsible for the most common form of hospital-acquired diarrhoea, affecting over 500,000 people in the United States and one out of every 1,000 patients hospitalised in Europe.
Alere International
|
blood transfusion
